Publications by authors named "Abdulmahsen Alsalman"
Drug Healthc Patient Saf
September 2024
Article Synopsis
- Sacubitril/valsartan (S/V) is a medication for heart failure with reduced ejection fraction (HFrEF), aimed at improving heart function and reducing hospitalizations.*
-
- A study with 107 patients showed no significant improvement in left ventricular ejection fraction (LVEF) after using S/V, although hospitalizations due to heart failure symptoms decreased numerically.*
-
- Overall, S/V was well tolerated but did not demonstrate a strong benefit for LVEF improvement, suggesting that heart failure clinics should carefully manage dosing for optimal results.*
